Affordable Access

Publisher Website

Retinoblastoma — Current treatment and future direction

Authors
Journal
Early Human Development
0378-3782
Publisher
Elsevier
Publication Date
Volume
86
Issue
10
Identifiers
DOI: 10.1016/j.earlhumdev.2010.08.022
Keywords
  • Retinoblastoma
  • Infant
  • Tumour
  • Ocular
  • Mutation
  • Heritable
  • Chemotherapy
  • Screening
  • Intra-Arterial
  • Enucleation
  • Cancer
Disciplines
  • Medicine

Abstract

Abstract Retinoblastoma is the commonest primary ocular malignancy of childhood. There are two forms — heritable and non heritable. Heritable retinoblastoma is a cancer susceptibility syndrome. Presentation is in the first few years of life, sometimes in the neonatal period. Early detection and prompt treatment can give cure rates up to 95% for intraocular tumours, but extraocular disease carries a very high mortality. The diagnosis is essentially clinical and biopsy is contraindicated due to the risk of extraocular spread. Treatment requires significant multidisciplinary input, with local ophthalmic treatment, systemic chemotherapy and external beam or plaque radiotherapy, or surgery to remove the affected eye. Screening of family members is essential for early detection. Lifelong surveillance of mutation carriers is needed due to the risk of second cancers. Newer treatment modalities including intra-arterial chemotherapy have been added to the therapeutic armamentarium in recent years.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

ACL treatment current trends and future directions...

on The journal of knee surgery January 2009

Current issues and future directions in treatment.

on Seminars in liver disease May 2006

Chemotherapy in retinoblastoma: current status and...

on The American journal of pediat... 1991

Treatment of testicular cancer: current status and...

on Japanese journal of clinical o... March 1990
More articles like this..